Reuters logo
BRIEF-Impax Laboratories says co entered into amendment no. 1 to business combination agreement with Atlas Holdings ​
November 21, 2017 / 10:27 PM / 24 days ago

BRIEF-Impax Laboratories says co entered into amendment no. 1 to business combination agreement with Atlas Holdings ​

Nov 21 (Reuters) - Impax Laboratories Inc

* Impax Laboratories Inc - ‍on Nov 21, co entered into amendment no. 1 to business combination agreement, dated October 17, 2017 with Atlas Holdings ​

* Impax Laboratories Inc - ‍also entered into amendment no. 1 with K2 Merger Sub Corporation & Amneal Pharmaceuticals Llc​

* Impax Laboratories Inc - ‍in connection with closing, Holdco will be renamed Amneal Pharmaceuticals, Inc.​

* Impax Laboratories - ‍in connection with pipe transaction, amneal desires to revise capital structure of new amneal to provide for class B-1 stock​ Source text: (bit.ly/2zXs2Wt) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below